| Response to COVID-19 vaccination post-CAR T therapy in patients with non-Hodgkin lymphoma and multiple myeloma JE Wiedmeier-Nutor, M Iqbal, AC Rosenthal, ED Bezerra, ... Clinical Lymphoma Myeloma and Leukemia 23 (6), 456-462, 2023 | 11 | 2023 |
| The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes JR Cerhan, MJ Maurer, BK Link, AL Feldman, TM Habermann, DL Jaye, ... American journal of hematology 99 (3), 408-421, 2024 | 3 | 2024 |
| Optimization of Electrospray Ionization for Liquid Chromatography Time-of-Flight Mass Spectrometry Analysis of Preservatives in Wood Leachate Matrix K Klara, G Brianna, S Fisher, A Kubátová Chromatographia 82, 1677-1685, 2019 | 3 | 2019 |
| Cumulative incidence, predictors, and outcomes of transformation to diffuse large B-cell lymphoma in a prospective cohort of patients with marginal zone lymphoma C Bommier, BK Link, B Gysbers, MJ Maurer, MC Larson, A Khurana, ... Blood 142, 1672, 2023 | 1 | 2023 |
| Comparison of Methotrexate Maintenance Versus Autologous Stem Cell Transplant Consolidation after High-Dose Methotrexate-Based Induction Therapy in Primary Central Nervous … SR Hwang, PB Johnston, RC Godby, B Gysbers, R Mwangi, I Micallef, ... Blood 142, 989, 2023 | 1 | 2023 |
| Methylated DNA markers for sporadic colorectal and endometrial cancer are strongly associated with lynch syndrome cancers RM Bramblet, JN Bakkum-Gamez, SW Slettedahl, PH Foote, WR Taylor, ... Cancer Prevention Research 16 (11), 611-620, 2023 | 1 | 2023 |
| Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes NJ Boddicker, R Mwangi, DP Robinson, C Allmer, AC Rosenthal, ... Blood 142, 2990, 2023 | | 2023 |
| Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study M Tsang, BN Noble, C Bommier, C Casulo, C Thompson, AC Rosenthal, ... Blood 142, 3761, 2023 | | 2023 |
| Impact of Frontline Treatment Strategy on Quality of Life in the First Decade after a Diagnosis of Marginal Zone Lymphoma C Bommier, M Tsang, BN Noble, C Thompson, C Strouse, C Casulo, ... Blood 142, 2394, 2023 | | 2023 |
| Primary Central Nervous System Lymphoma and Contemporary Clinical Prognostication RC Godby, SR Hwang, B Gysbers, R Mwangi, MJ Maurer, TE Witzig, ... Blood 142, 1768, 2023 | | 2023 |
| Lymphoma-Related Quality of Life (QOL) Is Not Impacted By Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma … C Bommier, M Tsang, BN Noble, C Thompson, C Casulo, M Hildebrandt, ... Blood 142, 2395, 2023 | | 2023 |
| Plasma Methylated DNA Markers for Melanoma Surveillance CK Berger, WR Taylor, DW Mahoney, KN Burger, KA Doering, AM Gonser, ... JCO Precision Oncology 7, e2300389, 2023 | | 2023 |
| Germline CHEK2 variants and risk of lymphoma NJ Boddicker, R Mwangi, DP Robinson, AC Rosenthal, TM Habermann, ... Cancer Research 83 (7_Supplement), 5233-5233, 2023 | | 2023 |
| Clinical Outcomes in Patients with Mantle Cell Lymphoma Who Received Autologous Stem Cell Transplant in the Second Line Setting JJ Gile, AM Bock, RK Tawfiq, MC Larson, K Poonsombudlert, SM Maliske, ... Blood 140 (Supplement 1), 6517-6519, 2022 | | 2022 |
| Tissue methylated DNA markers for sporadic pancreatic cancer are strongly associated with familial and genetically predisposed pancreatic cancer S Majumder, WR Taylor, PH Foote, BJ Gysbers, X Cao, DW Mahoney, ... Pancreatology 22 (6), 770-773, 2022 | | 2022 |
| Plasma methylated DNA markers of cutaneous melanoma: Association with PET/CT-positive disease. A Meves, WR Taylor, CK Berger, DW Mahoney, K Burger, E Quattrocchi, ... Journal of Clinical Oncology 40 (16_suppl), 9567-9567, 2022 | | 2022 |
| Methylated DNA markers in urine aid in the selective identification of patients with prostate cancer as well as clinically significant pathology. P Shah, WR Taylor, BJ Gysbers, DW Mahoney, SS Then, ME Devens, ... Journal of Clinical Oncology 40 (16_suppl), 5091-5091, 2022 | | 2022 |
| Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine Tumors S Majumder, TR Halfdanarson, CK Berger, PH Foote, X Cao, ... Gastro Hep Advances 1 (3), 409-416, 2022 | | 2022 |
| Sa287 DETECTION OF FAMILIAL AND GENETICALLY PREDISPOSED PANCREATIC CANCER BY ASSAY OF METHYLATED DNA MARKERS IN PANCREATIC TISSUE S Majumder, WR Taylor, PH Foote, BJ Gysbers, X Cao, DW Mahoney, ... Gastroenterology 160 (6), S-469-S-470, 2021 | | 2021 |
| Sa304 METHYLATED DNA MARKERS IN TISSUE FROM SURGICALLY RESECTED INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS DETECT HIGH-GRADE DYSPLASIA WITH OR WITHOUT INVASIVE CANCER IN THE FIELD S Majumder, R Graham, SW Slettedahl, BJ Gysbers, X Cao, PH Foote, ... Gastroenterology 160 (6), S-477-S-478, 2021 | | 2021 |
Karen DoeringMayo Clinic在 mayo.edu 的电子邮件经过验证
